Invited Speakers
Paul Marsden, United Kingdom
Paul Marsden is a Professor on PET Physics at the Division of image sciences and Biomedical Engineering of King’s College in London. He has been involved in PET imaging for most of his career and has worked in all aspects of the field from the production of new radionuclides and tracers to the development of clinical and research scanning protocols and data analysis.
He has a degree in physics from Oxford University and a PhD in Medical Physics from the Institute of Cancer Research. His PhD was on development of a multiwire proportional chamber PET scanner and was carried out in collabortion with the Rutherford Appleton Laboratory in Oxford. In 1992 Paul joined the PET Centre Imaging Centre at St Thomas’ Hospital in London when the unit was being established, and he is currently Scientific Director of the unit.
His research interests includes the development of combined PET and MRI imaging systems, data analysis methods for clinical and research PET studies, the development of radionuclide production methods and development of PET and PET-CT image acquisition methods including 3D PET and correction for patient motion. Much of this work is in collaboration with other clinical researchers in oncology, radiotherapy, cardiology and neuropsychiatry.
Paul is familiar with the various logistical and regulatory issues relating to PET studies and is network lead for the NCRI UK PET Research Network, that has been established to facilitate PET cancer research in the UK.
Michael Ljungberg, Sweden
Michael LJUNGBERG graduated in 1990 with a PhD thesis entitled “Development and Evaluation of Attenuation and Scatter Correction Techniques for SPECT using the Monte Carlo Method.” This work formed the start for the development of the Monte Carlo program, named SIMIND (www.radfys.lu.se/simind) that today is internationally recognized as a reliable and accurate program for scintillation-camera-based nuclear medicine imaging simulations and that is still maintained and developed with a large number of active users around the world.
His research has also focused on developments of attenuation and scatter correction methods for SPECT as well as for planar scintillation camera imaging and he has a broad international collaboration on this topic. His research group in Lund is mainly focused on dosimetry calculation and dose planning for radionuclide therapy but he has also been working on myocardial SPECT-imaging-related research and published several papers on the evaluation of accuracy when using standardized clinical quantification programs.
Together with several colleagues he develops programs and methods for both 2D and 3D dosimetry for applications in several clinical trials involving both Lu-177-labeled peptides and In-111/Y-90 labeled antibodies. His recent interest has been focused on applications of bremsstrahlung imaging for the verification of 90-Y based high-dose radionuclide therapy studies.
He is also involved in the Swedish under-graduate education for medical physicist at Lund University.
Marta Wasilewska-Radwanska, Poland
Marta Wasilewska-Radwanska was the Head of the Medical Physics and Biophysics Department (1995-2009) in the Faculty of Physics and Applied Computer Science and since 2006 Program Council member of the Multidisciplinary School of engineering In Biomedicine (MSIB) at the AGH University of Science and Technology Krakow, Poland.
She is specializing in dosimetry, non-ionizing radiation, medical imaging diagnostics and phantom (different organs) construction for testing various medical modalities, with a lot of years of teaching experience in medical physics.
She was the Vice President of the Polish Society of Medical Physics for ten years and she is, now, the Secretary General. Chair of the Education and Training Committee of EFOMP (2007-2010). Member of the Committee on Medical Physics, Radiobiology and Diagnostic Imaging and Chair of the Radiation Hygiene and Radiobiology Commission, Division VI Medical Sciences, Polish Academy of Sciences.
Anna Teresinska, Poland
Anna TERESINSKA graduated from the University of Warsaw, Poland, with an MSc in medical physics in 1981. She began her activity in nuclear medicine in 1981 and since 1986 she has worked at the Institute of Cardiology, Warsaw, where she is now the Head of the Nuclear Medicine Department.
PhD in medical sciences from the Medical Academy of Lodz, Poland, for research on the reconstruction, image processing and presentation techniques associated with nuclear cardiac imaging (1993). Habilitation in medical sciences from the Medical University of Warsaw for the dissertation on the radioisotopic assessment of the influence of cardiac surgery on perfusion and innervation of myocardium as well as for scientific, teaching and professional output (2009).
The author of a monograph on emission tomography in cardiology, 4 book-chapters, an educational video-film. The coordinator of the working group on the Polish standards for nuclear cardiology procedures (2000). The author of 47 papers (first author in 27) in Polish and in international scientific journals and of 121 abstracts (presenter of 52).
The investigator in 7 national scientific projects and in 7 international trials (Euroinject-One, STICH, OAT-NUC, DELTA MI, MBG311, MBG313, EVINCI) – a site-PI in 5 of them.
The chair of the Commission of Nuclear Medicine at the Polish Academy of Sciences since 1995, a member of the Atomic Council at the Chairman of Polish National Atomic Energy Agency since 2009, a member of the Board of the Polish Society of Nuclear Medicine (1990-2010). The Editor-in-Chief of the Polish Journal of Nuclear Medicine in the years 1998-2004. A member of the Polish Society of Nuclear Medicine (since 1987), the European Association of Nuclear Medicine (since 1988), the Polish Society of Cardiology (since 1992), the American Society of Nuclear Cardiology (since 2009).
Jure Fettich, Slovenia
Jure FETTICH was born in Ljubljana, Slovenia no April 28, 1951. He obtained his M.D. degree from the University of Ljubljana in 1976, completed specialisation in internal medicine in1983 and nuclear medicine in 1992, as well as his PhD study in nuclear cardiology in 1992 at the University of Ljubljana. He studied nuclear medicine, as, a British Council fellow, at St. Bartholomew’s Hospital in London from 1985 to 1986.
He has worked as a nuclear medicine physician at the Nuclear Medicine Department, University Medical Centre in Ljubljana since 1983 and at the Mubarak University Hospital, Kuwait (1988 and 1990). Currently he is employed as the Head of the Department for Nuclear Medicine Imaging of the University Medical Centre in Ljubljana.
He is teaching nuclear medicine undergraduate and postgraduate students at the Medical Faculty of the University of Ljubljana since 1984. As an expert in the field of nuclear medicine at the International Atomic Energy Agency, Vienna where he carried out several teaching courses and missions to developing countries.
He was involved in several European Union COST projects, IAEA co-ordinated research projects and served as Chairman of the EANM Paediatric Committee from 2001 to 2004 and as EANM Treasurer since 2010. He is also advisory editor of several nuclear medicine scientific journals (European Journal for Nuclear Medicine and Molecular Imaging, Nuclear Medicine Communications etc.).
John Buscombe, United Kingdom
John BUSCOMBE is presently a Consultant in Nuclear Medicine at Addenbrookes Hospital, Cambridge, UK, a Professor in Nuclear Medicine of University of Pretoria, South Africa. He was previously a Consultant in Nuclear Medicine at the Royal Free Hospital, London, UK. He is Hon Senior Lecturer in Medicine UCL, London, Chairperson of the FEBNM examination committee (2007-2010), Chairperson of the Nuclear Medicine SAC of the RCP (2008-2011), President of the IRIST (2006-2008). He has published 172 papers, 5 books, 35 book chapters and was invited to lecturer more than 400 in 75 countires.
Bieke LAMBERT, Belgium
Bieke LAMBERT studied medicine at the Ghent University, in Belgium and started her career in 2001 as a PhD student with a grant from the Ghent University. During these years she mainly focussed on research topics related to primary liver cancer. Her in vitro research involved spheroid tumour models and her clinical research consisted of the implementation of Rhenium-188 Lipiodol for radionuclide therapy of liver tumours.
She finished her 4 years of research grant with a PhD thesis entitled ‘New Strategies in Radionuclide Therapy for Hepatocellular Carcinoma’ (Sept. 2005). Subsequently she was in training in Groningen (UMCG) and Ghent to become a specialist in Nuclear Medicine (2008).
At present she works at the Ghent University Hospital as a medical staff member, with an emphasis on radionuclide therapy and PET/CT.
Glenn Flux, United Kingdom
Glenn Flux is the Head of Radioisotope Physics at the Royal Marsden Hospital and Institute of Cancer Research in Sutton, UK. He is a member of the European Association of Nuclear Medicine Dosimetry Committee and chair of the British Institute of Radiology on Molecular Radiotherapy, chair of the UK CTRad group on Molecular Radiotherapy and chair of the Dosimetry and Radiobiology working group of an EU COST action on Targeted Radionuclide Therapy. He has authored over 50 papers and several book chapters concerned with Molecular Imaging and dosimetry for Molecular Radiotherapy and he is the holder of several research grants.is Leader of the
Chariklia Giannopoulos, Greece
Dr. Chariklia GIANNOPOULOU is the director of the Nuclear Medicine and PET/CT Department of “Evangelismos” Hospital in Athens, Greece.
She received her M.D. from Athens University Medical School and specialized in Internal Medicine and Nuclear Medicine (NM). She is specially trained in Nuclear Cardiology at the Centre Hospitallier de Saint-Germain-en-Laye, Paris, France and the Killingbeck Hospital, Leeds, UK and in the field of PET/CT, as fellow at the Nuclear Medicine and PET/CT Department in Middlesex Hospital (UCL) in London. She also attended EANM courses on PET/CT and ESTRO-ESMO courses on Radiotherapy planning in Vienna.
With special interest in PET/CT, she is a founding member of AcroPET, an international Organization on creating communication channels between experts in nuclear medicine and more specifically in the domain of Positron Emission Tomography and is author of editorials and several scientific articles on this field.
As member of the Greek Committee of Ionizing Radiation, Secretary General of the Greek Society of Nuclear Medicine and Biology and national delegate in EANM, is a frequent consultant to the Ministry of Health on issues involving ΝΜ practice guidelines, international classification of procedures (ICD-10) and cost-effectiveness in the field of NM. In addition to her many scholarly articles, her work includes publications and projects in the areas of nuclear medicine in oncology and cardiology. She has authored or edited over 9 books and book-length supplements in such fields as daily practice guidelines in NM, evidence-based indications of PET/CT, orthopaedic NM.
Christina Fragkaki, Greece
Christina Fragkaki graduated from Semmelweis Medical University (English Programme) in 1995. She specialized in Nuclear Medicine both at the University Hospital of Patras and at “Evangelismos” General Hospital in Athens, Greece. She trained in PET/CT and Pediatric Nuclear Medicine as a Research Scholar at the University of Miami Hospital & Clinics/Sylvester Cancer Center (UMHC) and the Jackson Memorial Hospital in Miami-USA where, she also conducted daily teaching sessions in PET imaging to Nuclear Medicine residents.
She received her PhD degree in Nuclear Medicine from the Medical School of National and Kapodistrian University, in Athens, Greece for her research on “The use of WBC scintigraphy in the diagnosis of osteomyelitis in diabetic foot infections”. She has co-authored chapters in three scientific books (both in English and in Greek language) and has been a guest speaker in several medical conferences. She has attended numerous learning courses, workshops and continuing medical education sessions including the EANM courses on Clinical PET, the Advanced Learning Course on PET/CT in Oncology and the Cardiovascular Course in Vienna.
She is a member of the Educational Committee of the Greek Society of Nuclear Medicine and Biology, responsible for the Continuing Medical Education (CME) of Nuclear Medicine physicians and for the Educational Courses of the Nuclear Medicine residents in Greece. She is also a member of the European Association of Nuclear Medicine, the Greek Society of Nuclear Medicine and Biology, the Medical Association of Athens and the Association of Greek Private Nuclear Medicine Practitioners. Currently she is Head of the Nuclear Medicine Department in EUROMEDICA/Ambelokipoi Branch, a private medical diagnostics institution in Athens, Greece.
Dimitris Apostolopoulos, Greece
Dimitris Apostolopoulos in an Assistant Professor of Nuclear Medicine in the University of Patras, Greece. He is currently employed in the Department of Nuclear Medicine of the General University Hospital of Patras.
He was born in Patras, Greece in 1960. He received his MD in 1984 from the Medical School of the University of Athens and his Doctorate from the same University in 1989. He completed his specialization in Nuclear Medicine in the “Aretaieion” Hospital, Athens. He was trained in Nuclear Cardiology in the University Hospital “Haut-Leveque”, Bordeaux, France in 1988. In Janury 2010 he joined the Medical PET of the German Cancer Research Centre (Deutsches Krebsforschung Zentrum, DKFZ), Heidelberg, Germany, as participant in a research project.
His special interests are in Classical Nuclear Medicine, particularly in the fields of Nuclear Endocrinology and Ongology. His research work is mainly on parathyroid imaging, applications of SPECT/CT and noise reduction of scintigraphic images by Principal Component Analysis and Platelet-denoising based methods.
He has participated as a co-author in 28 scientific papers published in peer-reviewed medical journals. He has also edited or authored 3 books: “Introduction to Nuclear Medicine” for the students of the University of Patras, “Parathyroid Scintigraphy” and “Endoscopic Urology – Radioisotopic techniques in obstructive uropathy”. He has given approximately 50 lectures in Medical Congresses and CME sessions of various Medical Associations.
Phivi Rondogianni, Greece
Phivi RONDOGIANNI was born in Athens, Greece. In 1978 she entered the Medical School of The Athens National University after a successful national examination. She finished her studies in June 1984, began and completed her training in Internal Medicine at the departments of Internal Medicine and Cardiology of the General Hospital of Preveza. She began her training in Nuclear Medicine at the department of Nuclear Medicine of “Evangelismos” General Hospital in Athens and she continued and completed it at the University Hospital “Pellegrin”, the Regional Hospital “Haut – Leveque” Bordeaux, France as resident (Interne) in Nuclear Medicine. During her training in France she obtained the following diplomas:
-Diploma of Nuclear Magnetic Resonance (University of Rennes /France)
-Diploma of Radiobiology and Basic Physics of Radionuclides (University of Bordeaux II France).
-Diploma of “Pharmacologie Spéciale Approfondie” (University of Bordeaux II France).
She obtained the title of Specialist in Nuclear Medicine on the 16th of May 1989.
She also obtained a master’s title by thesis (M.D.) from the National University of Athens and the University of Bordeaux II (1990).
Since 2000 she is a Fellow of the European Board of Nuclear Medicine, have being working in the Nuclear Medicine Department of “Evagelismos” General Hospital in Athens since 1990 and in the PET/CT unit of the same Hospital since 1997. During this period she had participated in multiple Greek and Foreign publications, Congresses and Seminars as well as in the National Program of Continuing Education in Nuclear Medicine.
Nick Papathanasiou, Greece
Nick PAPATHANASIOU is currently a Nuclear Medicine Consultant at “Metropolitan” Hospital, Athens, Greece. He completed his training in “Evangelismos” Hospital, Athens and had 2-years of post training working experience in the Institute of Nuclear Medicine, University College Hospital, London, UK (previous post).
He has an MSc in Biostatistics. His research fields are radionuclide therapy, somatostatin receptor PET/CT imaging and combined PET perfusion-CT angiography cardiac imaging.